IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Hospitals and facilities in Ohio

In 2025 Q1–Q4, the provider or facility offer prevailed in 94.3% of 2,369 determined Federal IDR dispute line items for hospitals and facilities in Ohio. The median prevailing offer was 3.28x the QPA (25th–75th percentile 1.91x–5.41x; n = 887). The median time to a decision was 38 business days (n = 2,369).

Determined line items

2,369

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

94.3%

n = 2,369 · 2025 Q1–Q4

Median payment vs QPA

3.28x

middle half 1.91x–5.41x · n = 887 · 2025 Q1–Q4

Median days to decision

38

business days, from dispute initiation · n = 2,369 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q42,36994.3%3.28x1.91x–5.41x88738
2024 Q1–Q454392.4%1.07x1.07x–3.60x22453
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q42,91393.9%2.52x1.10x–5.27x1,112not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
85025 Complete blood cell count (red cells, white blood cell, platelets), automated te11995.8%3.15x3638
36415 Insertion of needle into vein for collection of blood sample10295.1%–2635
80053 Blood test, comprehensive group of blood chemicals8695.3%–2745
99285 Emergency department visit with high level of medical decision making8196.3%2.22x6638
96361 Infusion into a vein for hydration, each additional hour5793.0%–2732
99233 Subsequent hospital care with moderate levelof medical decision making, if using5777.2%4.53x5525
96374 Injection of drug or substance into vein5592.7%–2535
81001 Manual urinalysis test with examination using microscope, automated5094.0%–1333
83690 Lipase (fat enzyme) level4693.5%–1442.5
84484 Troponin (protein) analysis, quantitative4695.7%–1138.5
96375 Injection of additional new drug or substance into vein4693.5%–2337.5
83735 Magnesium level44100.0%–1537
71045 X-ray of chest, 1 view42100.0%–2436
93005 Routine electrocardiogram (ECG) using at least 12 leads with tracing4292.9%–837
99284 Emergency department visit with moderate level of medical decision making4295.2%2.93x3337.5
83605 Lactic acid level3889.5%–1240.5
87804 Detection test by immunoassay with direct visual observation for influenza virus3889.5%–1032
80048 Blood test, basic group of blood chemicals (Calcium, total)3697.2%–924.5
74176 CT scan of abdomen and pelvis without contrast3497.1%–1334

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Ohio · Hospitals and facilities in all states

FAQ

What is the Federal IDR provider win rate for hospitals and facilities in Ohio?

In 2025 Q1–Q4, the provider or facility offer was selected in 94.3% of 2,369 determined dispute line items for hospitals and facilities in Ohio. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for hospitals and facilities in Ohio?

In 2025 Q1–Q4, the median prevailing offer was 3.28x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.91x to 5.41x (n = 887 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for hospitals and facilities in Ohio?

In 2025 Q1–Q4, the median was 38 business days (n = 2,369 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR